DEBN
Gdansk, Pomorskie, Poland
About DEBN
DEBN (Drug-Eluting Biopsy Needle) is a medical company developing a novel prostate biopsy needle for urologists which will reduce infectious complication rate. Prostate biopsy needle delivers the optimal antibiotic combination directly to the prostate, precisely at the place where potential infections start. This application method allows to use a more effective antibiotic which is not allowed for oral prophylaxis.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Non-Equity Assistance (May 2019)
- Website: debn.eu
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/debn-2486435 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.